BIOMX INC (PHGE) Stock Income Statement
NYSEARCA:PHGE - NYSE Arca - US09090D3017 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | N/A | 0.00 | 0.00 | |||
| Operating Expenses | 37.41M | 36.44M | 25.35M | 27.22M | 35.46M | |||
| Research and Development | 25.81M | 23.18M | 15.92M | 15.34M | 21.69M | |||
| Selling, General, and Administrative Expenses | 11.60M | 11.78M | 8.65M | 9.46M | 11.27M | |||
| Operating Income | -37.41M | -36.44M | -25.35M | -27.22M | -35.46M | |||
| Interest Income/Expense | 35.40M | 26.58M | -1.10M | -1.15M | -690.00K | |||
| Other Income/Expense | 2.05M | 230.00K | 301.00K | 120.00K | -10.00K | |||
| Non Recurring Items | N/A | -8.08M | N/A | N/A | N/A | |||
| Income Before Taxes | -8.05M | -17.71M | -26.15M | -28.25M | -36.16M | |||
| Income Tax | 9.00K | 13.00K | 23.00K | 70.00K | 70.00K | |||
| Net Income | -8.06M | -17.73M | -26.17M | -28.32M | -36.23M | |||
| EBITDA | -35.60M | -34.64M | -24.48M | -24.70M | -32.89M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.50 | -1.47 | -0.51 | -0.95 | -1.39 | |||
| Non GAAP EPS | N/A | N/A | -5.30 | -9.40 | -13.90 | |||
| Statistics | ||||||||
All data in USD